Implementing oral (event-driven and daily) and long-acting pre-exposure prophylaxis in mobile men in sub-Saharan Africa: a phase 3b, open-label, hybrid type 2 implementation and effectiveness trial (MOBILE MEN). - Kusemererwa S; Nayiga B; Lebina L; Bekker LG; Philips A; Matharu LB; Govindasamy D; Meyer-Rath G; Kimbugwe G; Ruzagira E; Shahmanesh M; Seeley J; et al. (Trials, 2025)